BRIDGEWAY CAPITAL MANAGEMENT, LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 112 filers reported holding CYTOKINETICS INC in Q1 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2014$256,000
-49.8%
53,6330.0%0.01%
-53.3%
Q1 2014$510,000
+46.1%
53,6330.0%0.02%
+36.4%
Q4 2013$349,000
-14.0%
53,6330.0%0.01%
-21.4%
Q3 2013$406,00053,6330.01%
Other shareholders
CYTOKINETICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$7,286,7218.83%
Saturn V Capital Management LP 406,225$13,251,0607.35%
Logos Global Management LP 1,650,000$53,823,0007.32%
Finepoint Capital LP 369,093$12,039,8144.16%
GREAT POINT PARTNERS LLC 600,000$19,572,0003.83%
Boxer Capital, LLC 2,100,000$68,5023.18%
PFM Health Sciences, LP 2,399,545$78,273,1583.04%
DAFNA Capital Management LLC 332,734$10,853,7832.97%
Integral Health Asset Management, LLC 650,000$21,203,0002.62%
Sofinnova Investments, Inc. 843,228$27,506,0971.80%
View complete list of CYTOKINETICS INC shareholders